Immatics N.V.(IMTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IMTX Immatics N.V.

盘后交易 10-21 19:24:54 EDT

7.69

+0.18

+2.40%

盘后7.69

+0.000.00%

16:47 EDT

最高7.95	最低7.61	成交量198.04万
今开7.62	昨收7.51	日振幅4.53%
总市值11.54亿	流通市值6.39亿	总股本1.50亿
成交额1,540万	换手率2.38%	流通股本8,307万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IMTX","market":"US","secType":"STK","nameCN":"Immatics N.V.","latestPrice":7.69,"timestamp":1792612800000,"preClose":7.51,"halted":0,"volume":1980382,"hourTrading":{"tag":"盘后","latestPrice":7.69,"preClose":7.69,"latestTime":"16:47 EDT","volume":7984,"amount":61397.1093008,"timestamp":1792615630471,"change":0,"changeRate":0,"amplitude":0.019506},"delay":0,"changeRate":0.02396804260985361,"floatShares":83065400,"shares":150000000,"eps":-1.828543,"marketStatus":"盘后交易","change":0.18,"latestTime":"10-21 19:24:54 EDT","open":7.62,"high":7.95,"low":7.61,"amount":15399904.7316308,"amplitude":0.045273,"askPrice":9.68,"askSize":100,"bidPrice":7.35,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-1.828543,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1792627200000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":7.51,"preHourTrading":{"tag":"盘前","latestPrice":7.67,"preClose":7.51,"latestTime":"09:26 EDT","volume":304,"amount":2331.665712,"timestamp":1792589217570,"change":0.16,"changeRate":0.021305,"amplitude":0.029587},"postHourTrading":{"tag":"盘后","latestPrice":7.69,"preClose":7.69,"latestTime":"16:47 EDT","volume":7984,"amount":61397.1093008,"timestamp":1792615630471,"change":0,"changeRate":0,"amplitude":0.019506},"volumeRatio":1.455006,"impliedVol":1.6614,"impliedVolPercentile":0.996},"requestUrl":"/m/hq/s/IMTX/wiki","defaultTab":"wiki","newsList":[{"id":"2517496129","title":"Immatics N.V.盘中异动 快速上涨5.07%报4.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517496129","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517496129?lang=zh_cn&edition=full","pubTime":"2025-03-05 23:35","pubTimestamp":1741188909,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日23时35分，Immatics N.V.股票出现异动，股价急速拉升5.07%。截至发稿，该股报4.56美元/股，成交量15.1305万股，换手率0.12%，振幅4.15%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为1.21%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305233510963aeccc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305233510963aeccc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514049232","title":"Immatics N.V.盘中异动 临近收盘股价大跌5.27%报4.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514049232","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514049232?lang=zh_cn&edition=full","pubTime":"2025-02-26 04:54","pubTimestamp":1740516876,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日04时54分，Immatics N.V.股票出现异动，股价急速下跌5.27%。截至发稿，该股报4.41美元/股，成交量31.5867万股，换手率0.26%，振幅5.91%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为0.06%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226045436a253de03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226045436a253de03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510803843","title":"Immatics N.V.盘中异动 早盘股价大跌5.41%报4.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510803843","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510803843?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:43","pubTimestamp":1739285034,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时43分，Immatics N.V.股票出现异动，股价大幅跳水5.41%。截至发稿，该股报4.99美元/股，成交量3.7235万股，换手率0.03%，振幅3.61%。Immatics N.V.股票所在的生物技术行业中，整体跌幅为1.36%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211224354abcb08fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211224354abcb08fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509775354","title":"Immatics N.V.盘中异动 快速下跌5.04%报5.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509775354","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509775354?lang=zh_cn&edition=full","pubTime":"2025-02-08 04:01","pubTimestamp":1738958481,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日04时01分，Immatics N.V.股票出现波动，股价快速跳水5.04%。截至发稿，该股报5.37美元/股，成交量23.8529万股，换手率0.20%，振幅4.78%。Immatics N.V.股票所在的生物技术行业中，整体跌幅为0.66%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208040121961b6f8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208040121961b6f8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509234140","title":"Immatics N.V.盘中异动 快速上涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509234140","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509234140?lang=zh_cn&edition=full","pubTime":"2025-02-06 01:31","pubTimestamp":1738776697,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日01时31分，Immatics N.V.股票出现异动，股价急速拉升5.07%。截至发稿，该股报5.70美元/股，成交量15.5771万股，换手率0.13%，振幅6.27%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为2.00%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206013137961926c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206013137961926c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508272991","title":"Immatics N.V.盘中异动 下午盘急速下挫5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508272991","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508272991?lang=zh_cn&edition=full","pubTime":"2025-02-04 04:13","pubTimestamp":1738613586,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日04时13分，Immatics N.V.股票出现异动，股价大幅下跌5.03%。截至发稿，该股报5.20美元/股，成交量24.6576万股，换手率0.20%，振幅3.66%。Immatics N.V.股票所在的生物技术行业中，整体跌幅为0.29%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020404130698799d30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020404130698799d30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504485299","title":"Immatics N.V.盘中异动 股价大跌5.04%报5.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504485299","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504485299?lang=zh_cn&edition=full","pubTime":"2025-01-17 01:27","pubTimestamp":1737048434,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日01时27分，Immatics N.V.股票出现异动，股价快速下跌5.04%。截至发稿，该股报5.46美元/股，成交量26.5531万股，换手率0.22%，振幅5.48%。Immatics N.V.股票所在的生物技术行业中，整体跌幅为0.21%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117012714abad75de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117012714abad75de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503640319","title":"Immatics N.V.盘中异动 大幅上涨5.86%报6.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503640319","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503640319?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:32","pubTimestamp":1736951553,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时32分，Immatics N.V.股票出现波动，股价快速上涨5.86%。截至发稿，该股报6.32美元/股，成交量1.1635万股，换手率0.01%，振幅3.18%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为0.77%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152232349604b426&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152232349604b426&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503708584","title":"Immatics N.V.盘中异动 早盘快速下跌5.44%报6.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503708584","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503708584?lang=zh_cn&edition=full","pubTime":"2025-01-14 00:01","pubTimestamp":1736784090,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日00时01分，Immatics N.V.股票出现异动，股价急速跳水5.44%。截至发稿，该股报6.08美元/股，成交量15.5791万股，换手率0.13%，振幅5.37%。Immatics N.V.股票所在的生物技术行业中，整体跌幅为0.95%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114000130aba94707&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114000130aba94707&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502681356","title":"Immatics N.V.盘中异动 下午盘股价大跌5.02%报6.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502681356","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502681356?lang=zh_cn&edition=full","pubTime":"2025-01-11 02:15","pubTimestamp":1736532937,"startTime":"0","endTime":"0","summary":"北京时间2025年01月11日02时15分，Immatics N.V.股票出现异动，股价快速下挫5.02%。截至发稿，该股报6.62美元/股，成交量21.8234万股，换手率0.18%，振幅5.60%。Immatics N.V.股票所在的生物技术行业中，整体跌幅为1.94%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111021537aba63414&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111021537aba63414&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500412957","title":"Immatics N.V.盘中异动 临近收盘股价大跌5.05%报7.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500412957","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500412957?lang=zh_cn&edition=full","pubTime":"2025-01-04 04:34","pubTimestamp":1735936450,"startTime":"0","endTime":"0","summary":"北京时间2025年01月04日04时34分，Immatics N.V.股票出现异动，股价快速下跌5.05%。截至发稿，该股报7.05美元/股，成交量42.4681万股，换手率0.35%，振幅5.93%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为0.63%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104043410a214b039&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104043410a214b039&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500292070","title":"Immatics N.V.盘中异动 快速拉升5.06%报7.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500292070","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500292070?lang=zh_cn&edition=full","pubTime":"2025-01-02 23:15","pubTimestamp":1735830910,"startTime":"0","endTime":"0","summary":"北京时间2025年01月02日23时15分，Immatics N.V.股票出现波动，股价急速上涨5.06%。截至发稿，该股报7.47美元/股，成交量8.7296万股，换手率0.07%，振幅5.63%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为0.96%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102231510ab9c0175&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102231510ab9c0175&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492153781","title":"Immatics N.V.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492153781","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492153781?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:05","pubTimestamp":1734552357,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时05分，Immatics N.V.股票出现波动，股价快速下跌5.01%。截至发稿，该股报6.82美元/股，成交量56.4613万股，换手率0.46%，振幅6.27%。Immatics N.V.股票所在的生物技术行业中，整体跌幅为2.02%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219040557a1f94cbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219040557a1f94cbf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2491500377","title":"Immatics N.V.盘中异动 早盘大幅下跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491500377","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2491500377?lang=zh_cn&edition=full","pubTime":"2024-12-14 00:26","pubTimestamp":1734107216,"startTime":"0","endTime":"0","summary":"北京时间2024年12月14日00时26分，Immatics N.V.股票出现波动，股价快速下跌5.13%。截至发稿，该股报7.03美元/股，成交量16.4401万股，换手率0.14%，振幅4.32%。Immatics N.V.股票所在的生物技术行业中，整体跌幅为0.47%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121400265795e97bea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121400265795e97bea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2487059814","title":"Immatics N.V.盘中异动 大幅上涨5.06%报8.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2487059814","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2487059814?lang=zh_cn&edition=full","pubTime":"2024-11-30 01:46","pubTimestamp":1732902417,"startTime":"0","endTime":"0","summary":"北京时间2024年11月30日01时46分，Immatics N.V.股票出现波动，股价急速上涨5.06%。截至发稿，该股报8.31美元/股，成交量19.5177万股，换手率0.16%，振幅5.18%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为0.23%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241130014657a25fcf80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241130014657a25fcf80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2485620098","title":"Immatics N.V.2024财年第三财季实现净利润-9.41百万美元，同比增加67.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485620098","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2485620098?lang=zh_cn&edition=full","pubTime":"2024-11-24 00:00","pubTimestamp":1732377628,"startTime":"0","endTime":"0","summary":"11月24日，Immatics N.V.公布财报，公告显示公司2024财年第三财季净利润为-9.41百万美元，同比增加67.35%；其中营业收入为55.54百万美元，同比增加761.09%，每股基本收益为-0.09美元。从资产负债表来看，Immatics N.V.总负债2.17亿美元，其中短期债务19.63百万美元，资产负债比为2.97，流动比率为3.98。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241124000052a2504586&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241124000052a2504586&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2483530595","title":"Immatics N.V.盘中异动 股价大跌5.04%报8.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483530595","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2483530595?lang=zh_cn&edition=full","pubTime":"2024-11-15 23:47","pubTimestamp":1731685663,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日23时47分，Immatics N.V.股票出现波动，股价大幅跳水5.04%。截至发稿，该股报8.10美元/股，成交量17.9562万股，换手率0.15%，振幅6.57%。Immatics N.V.股票所在的生物技术行业中，整体跌幅为3.35%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115234744971a6e72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115234744971a6e72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2483039219","title":"Immatics N.V.盘中异动 股价大跌5.09%报8.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483039219","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2483039219?lang=zh_cn&edition=full","pubTime":"2024-11-13 01:10","pubTimestamp":1731431413,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日01时10分，Immatics N.V.股票出现异动，股价大幅下挫5.09%。截至发稿，该股报8.58美元/股，成交量32.0911万股，换手率0.27%，振幅4.09%。Immatics N.V.股票所在的生物技术行业中，整体跌幅为0.70%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111301101398e4224a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111301101398e4224a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2474746561","title":"Immatics N.V.盘中异动 快速跳水5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474746561","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2474746561?lang=zh_cn&edition=full","pubTime":"2024-10-10 21:34","pubTimestamp":1728567242,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日21时34分，Immatics N.V.股票出现异动，股价快速下挫5.15%。截至发稿，该股报10.50美元/股，成交量16.588万股，换手率0.16%，振幅6.68%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为0.00%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010213402959da392&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010213402959da392&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2473899115","title":"Immatics N.V.盘中异动 急速拉升5.17%报10.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473899115","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2473899115?lang=zh_cn&edition=full","pubTime":"2024-10-05 03:26","pubTimestamp":1728069999,"startTime":"0","endTime":"0","summary":"北京时间2024年10月05日03时26分，Immatics N.V.股票出现异动，股价快速上涨5.17%。截至发稿，该股报10.88美元/股，成交量19.129万股，换手率0.19%，振幅3.91%。Immatics N.V.股票所在的生物技术行业中，整体跌幅为0.12%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241005032639ab67c4a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241005032639ab67c4a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immatics.com","stockEarnings":[{"period":"1week","weight":0.0996},{"period":"1month","weight":-0.1288},{"period":"3month","weight":-0.181},{"period":"6month","weight":-0.3265},{"period":"1year","weight":-0.3148},{"period":"ytd","weight":-0.2848}],"compareEarnings":[{"period":"1week","weight":-0.0115},{"period":"1month","weight":0.0097},{"period":"3month","weight":0.029},{"period":"6month","weight":0.0855},{"period":"1year","weight":0.1456},{"period":"ytd","weight":0.1278}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Immatics N.V.于2020年3月10日成立，是一家荷兰私人有限责任公司。该公司是一家专注于开发基于T细胞受体的免疫疗法的生物制药公司。","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.095881},{"month":2,"riseRate":0.666667,"avgChangeRate":-0.027168},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.054372},{"month":4,"riseRate":0.666667,"avgChangeRate":0.044854},{"month":5,"riseRate":0.666667,"avgChangeRate":0.078524},{"month":6,"riseRate":0.666667,"avgChangeRate":0.055475},{"month":7,"riseRate":0.833333,"avgChangeRate":0.074389},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.018575},{"month":9,"riseRate":0.428571,"avgChangeRate":0.07083},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.039977},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.02935},{"month":12,"riseRate":0.5,"avgChangeRate":0.016402}],"exchange":"NASDAQ","name":"Immatics N.V.","nameEN":"Immatics N.V."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immatics N.V.(IMTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Immatics N.V.(IMTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Immatics N.V.,IMTX,Immatics N.V.股票,Immatics N.V.股票老虎,Immatics N.V.股票老虎国际,Immatics N.V.行情,Immatics N.V.股票行情,Immatics N.V.股价,Immatics N.V.股市,Immatics N.V.股票价格,Immatics N.V.股票交易,Immatics N.V.股票购买,Immatics N.V.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immatics N.V.(IMTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Immatics N.V.(IMTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}